ArticleOncotarget2015
CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations.
Anchit Khanna et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleOncotarget2015
Anchit Khanna et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.